BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lakatos PL. Use of new once-daily 5-aminosalicylic acid preparations in the treatment of ulcerative colitis: Is there anything new under the sun? World J Gastroenterol 2009; 15(15): 1799-1804 [PMID: 19370774 DOI: 10.3748/wjg.15.1799]
URL: https://www.wjgnet.com/1007-9327/full/v15/i15/1799.htm
Number Citing Articles
Bei Ye, Daniel R van Langenberg. Mesalazine preparations for the treatment of ulcerative colitis: Are all created equal?World Journal of Gastrointestinal Pharmacology and Therapeutics 2015; 6(4): 137-144 doi: 10.4292/wjgpt.v6.i4.137
Yellela S. R. Krishnaiah, Mansoor A. Khan. Strategies of targeting oral drug delivery systems to the colon and their potential use for the treatment of colorectal cancerPharmaceutical Development and Technology 2012; 17(5): 521 doi: 10.3109/10837450.2012.696268
Eriko Yasutomi, Sakiko Hiraoka, Shumpei Yamamoto, Shohei Oka, Mami Hirai, Yasushi Yamasaki, Toshihiro Inokuchi, Hideaki Kinugasa, Masahiro Takahara, Keita Harada, Jun Kato, Hiroyuki Okada. Switching between Three Types of Mesalazine Formulation and Sulfasalazine in Patients with Active Ulcerative Colitis Who Have Already Received High-Dose Treatment with These AgentsJournal of Clinical Medicine 2019; 8(12): 2109 doi: 10.3390/jcm8122109
Glenn Lemmens, Arno Van Camp, Stephanie Kourula, Tim Vanuytsel, Patrick Augustijns. Drug Disposition in the Lower Gastrointestinal Tract: Targeting and MonitoringPharmaceutics 2021; 13(2): 161 doi: 10.3390/pharmaceutics13020161
N. Weiler, I. Thrun, M. Eberlin, D. Foltys, M. Heise, M. Hoppe-Lotichius, T. Zimmermann, I. Kraemer, G. Otto. Tacrolimus Effects and Side Effects After Liver Transplantation: Is There a Difference Between Immediate and Extended Release?Transplantation Proceedings 2013; 45(6): 2321 doi: 10.1016/j.transproceed.2013.03.039
L. Peyrin-Biroulet, M. Lémann. Review article: remission rates achievable by current therapies for inflammatory bowel diseaseAlimentary Pharmacology & Therapeutics 2011; 33(8): 870 doi: 10.1111/j.1365-2036.2011.04599.x
Wolfgang Kruis, Ludger Leifeld, Julia Morgenstern, Roland Pfützer, Birgitta Reimers, Sabine Ceplis-Kastner. The effect of third-party reporting on adoption of evidence-based mesalazine regimens in ulcerative colitis: An observational studyJournal of Crohn's and Colitis 2013; 7(4): e125 doi: 10.1016/j.crohns.2012.07.004